Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.9326
-0.0474 (-4.79%)
At close: Mar 31, 2025, 4:00 PM
0.9730
+0.0404 (4.33%)
After-hours: Mar 31, 2025, 8:00 PM EDT
Milestone Scientific Market Cap
Milestone Scientific has a market cap or net worth of $72.64 million as of April 1, 2025. Its market cap has increased by 45.87% in one year.
Market Cap
72.64M
Enterprise Value
68.18M
1-Year Change
45.87%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since December 1, 1998, Milestone Scientific's market cap has increased from $9.90M to $72.64M, an increase of 633.76%. That is a compound annual growth rate of 7.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 77.10M | 3.07% |
Dec 31, 2024 | 74.80M | 52.65% |
Dec 29, 2023 | 49.00M | 46.27% |
Dec 30, 2022 | 33.50M | -76.04% |
Dec 31, 2021 | 139.80M | 3.56% |
Dec 31, 2020 | 135.00M | 98.82% |
Dec 31, 2019 | 67.90M | 506.25% |
Dec 31, 2018 | 11.20M | -71.28% |
Dec 29, 2017 | 39.00M | -0.76% |
Dec 30, 2016 | 39.30M | -22.18% |
Dec 31, 2015 | 50.50M | 3.27% |
Dec 31, 2014 | 48.90M | 63.55% |
Dec 31, 2013 | 29.90M | 32.30% |
Dec 31, 2012 | 22.60M | 303.57% |
Dec 30, 2011 | 5.60M | -63.16% |
Dec 31, 2010 | 15.20M | -41.09% |
Dec 31, 2009 | 25.80M | 637.14% |
Dec 31, 2008 | 3.50M | -82.50% |
Dec 31, 2007 | 20.00M | 47.06% |
Dec 29, 2006 | 13.60M | -15.00% |
Dec 30, 2005 | 16.00M | -7.51% |
Dec 31, 2004 | 17.30M | -7.98% |
Dec 31, 2003 | 18.80M | 394.74% |
Dec 31, 2002 | 3.80M | -38.71% |
Dec 31, 2001 | 6.20M | -55.71% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |